BioAffinity Historical Financial Ratios

BIAF Stock

USD 0.26 0.01 3.70%

BioAffinity Technologies, is presently reporting on over 88 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 2.5 or Days Sales Outstanding of 128 will help investors to properly organize and evaluate bioAffinity Technologies, financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more detail on how to invest in BioAffinity Stock please use our How to Invest in BioAffinity Technologies, guide.

About BioAffinity Financial Ratios Analysis

bioAffinity Technologies,Financial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate BioAffinity Technologies, investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on BioAffinity financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across BioAffinity Technologies, history.

BioAffinity Technologies, Financial Ratios Chart

At this time, BioAffinity Technologies,'s PB Ratio is most likely to increase significantly in the upcoming years. The BioAffinity Technologies,'s current Inventory Turnover is estimated to increase to 89.00, while Operating Cash Flow Per Share is projected to decrease to (0.83).

Price To Sales Ratio Days Sales Outstanding Average Payables Inventory Turnover

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing bioAffinity Technologies, stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on BioAffinity Technologies, sales, a figure that is much harder to manipulate than other bioAffinity Technologies, multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Most ratios from BioAffinity Technologies,'s fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into bioAffinity Technologies, current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more detail on how to invest in BioAffinity Stock please use our How to Invest in BioAffinity Technologies, guide.At this time, BioAffinity Technologies,'s PB Ratio is most likely to increase significantly in the upcoming years. The BioAffinity Technologies,'s current Inventory Turnover is estimated to increase to 89.00, while Operating Cash Flow Per Share is projected to decrease to (0.83).

	2022	2023	2024	2025 (projected)
Payables Turnover	0.001353	2.88	2.59	2.72
Days Of Inventory On Hand	4.3K	3.88	4.46	4.23

Payables Turnover Days Of Inventory On Hand

BioAffinity Technologies, fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow
Price To Sales Ratio		-0.76	1.0	-0.41	0.78	0.74	-0.8	0.19	-0.76	-1.0	0.71	0.64	-1.0	0.4	0.29	-0.99	1.0	-0.07	-0.82	1.0	-0.18	-0.82	0.14	0.11	0.93	-0.78
Ptb Ratio	-0.76		-0.76	0.42	-0.86	-0.82	0.84	0.38	1.0	0.76	-0.81	-0.98	0.76	-0.86	0.27	0.66	-0.76	0.5	0.8	-0.72	-0.37	0.8	0.36	-0.62	-0.92	0.75
Days Sales Outstanding	1.0	-0.76		-0.41	0.78	0.74	-0.8	0.19	-0.76	-1.0	0.71	0.64	-1.0	0.4	0.29	-0.99	1.0	-0.07	-0.82	1.0	-0.18	-0.82	0.14	0.11	0.93	-0.78
Book Value Per Share	-0.41	0.42	-0.41		-0.81	-0.85	0.45	0.19	0.42	0.41	-0.86	-0.27	0.41	-0.59	0.03	0.4	-0.41	0.78	0.83	-0.41	-0.2	0.83	0.68	0.18	-0.59	0.88
Free Cash Flow Yield	0.78	-0.86	0.78	-0.81		0.99	-0.8	-0.26	-0.86	-0.78	0.99	0.75	-0.77	0.82	-0.11	-0.71	0.78	-0.67	-0.99	0.76	0.27	-0.99	-0.51	0.25	0.94	-0.98
Operating Cash Flow Per Share	0.74	-0.82	0.74	-0.85	0.99		-0.72	-0.25	-0.82	-0.74	1.0	0.7	-0.73	0.82	-0.09	-0.68	0.74	-0.71	-0.98	0.72	0.26	-0.98	-0.55	0.23	0.91	-0.98
Average Payables	-0.8	0.84	-0.8	0.45	-0.8	-0.72		0.28	0.84	0.8	-0.71	-0.77	0.8	-0.6	0.18	0.74	-0.8	0.34	0.78	-0.77	-0.28	0.78	0.2	-0.19	-0.87	0.74
Capex To Depreciation	0.19	0.38	0.19	0.19	-0.26	-0.25	0.28		0.38	-0.19	-0.27	-0.47	-0.2	-0.63	0.99	-0.31	0.19	0.68	0.13	0.23	-1.0	0.13	0.73	-0.57	-0.12	0.12
Pb Ratio	-0.76	1.0	-0.76	0.42	-0.86	-0.82	0.84	0.38		0.76	-0.81	-0.98	0.76	-0.86	0.27	0.66	-0.76	0.5	0.8	-0.72	-0.37	0.8	0.36	-0.62	-0.92	0.75
Ev To Sales	-1.0	0.76	-1.0	0.41	-0.78	-0.74	0.8	-0.19	0.76		-0.71	-0.64	1.0	-0.4	-0.29	0.99	-1.0	0.07	0.82	-1.0	0.18	0.82	-0.14	-0.11	-0.93	0.78
Free Cash Flow Per Share	0.71	-0.81	0.71	-0.86	0.99	1.0	-0.71	-0.27	-0.81	-0.71		0.69	-0.71	0.83	-0.12	-0.65	0.71	-0.73	-0.98	0.7	0.28	-0.98	-0.58	0.24	0.9	-0.98
Roic	0.64	-0.98	0.64	-0.27	0.75	0.7	-0.77	-0.47	-0.98	-0.64	0.69		-0.63	0.86	-0.38	-0.52	0.64	-0.47	-0.67	0.6	0.45	-0.67	-0.36	0.75	0.82	-0.61
Inventory Turnover	-1.0	0.76	-1.0	0.41	-0.77	-0.73	0.8	-0.2	0.76	1.0	-0.71	-0.63		-0.39	-0.3	0.99	-1.0	0.06	0.82	-0.99	0.19	0.82	-0.14	-0.1	-0.92	0.78
Net Income Per Share	0.4	-0.86	0.4	-0.59	0.82	0.82	-0.6	-0.63	-0.86	-0.4	0.83	0.86	-0.39		-0.51	-0.28	0.4	-0.84	-0.73	0.37	0.62	-0.73	-0.77	0.65	0.71	-0.71
Days Of Inventory On Hand	0.29	0.27	0.29	0.03	-0.11	-0.09	0.18	0.99	0.27	-0.29	-0.12	-0.38	-0.3	-0.51		-0.4	0.29	0.56	-0.03	0.33	-0.98	-0.03	0.63	-0.56	0.01	-0.04
Payables Turnover	-0.99	0.66	-0.99	0.4	-0.71	-0.68	0.74	-0.31	0.66	0.99	-0.65	-0.52	0.99	-0.28	-0.4		-0.99	-0.02	0.78	-0.99	0.3	0.78	-0.23	0.01	-0.87	0.75
Capex To Revenue	1.0	-0.76	1.0	-0.41	0.78	0.74	-0.8	0.19	-0.76	-1.0	0.71	0.64	-1.0	0.4	0.29	-0.99		-0.07	-0.82	1.0	-0.18	-0.82	0.14	0.11	0.93	-0.78
Cash Per Share	-0.07	0.5	-0.07	0.78	-0.67	-0.71	0.34	0.68	0.5	0.07	-0.73	-0.47	0.06	-0.84	0.56	-0.02	-0.07		0.6	-0.03	-0.68	0.6	0.98	-0.31	-0.41	0.63
Pocfratio	-0.82	0.8	-0.82	0.83	-0.99	-0.98	0.78	0.13	0.8	0.82	-0.98	-0.67	0.82	-0.73	-0.03	0.78	-0.82	0.6		-0.81	-0.14	1.0	0.43	-0.12	-0.94	1.0
Interest Coverage	1.0	-0.72	1.0	-0.41	0.76	0.72	-0.77	0.23	-0.72	-1.0	0.7	0.6	-0.99	0.37	0.33	-0.99	1.0	-0.03	-0.81		-0.22	-0.81	0.17	0.08	0.91	-0.77
Capex To Operating Cash Flow	-0.18	-0.37	-0.18	-0.2	0.27	0.26	-0.28	-1.0	-0.37	0.18	0.28	0.45	0.19	0.62	-0.98	0.3	-0.18	-0.68	-0.14	-0.22		-0.14	-0.73	0.54	0.13	-0.13
Pfcf Ratio	-0.82	0.8	-0.82	0.83	-0.99	-0.98	0.78	0.13	0.8	0.82	-0.98	-0.67	0.82	-0.73	-0.03	0.78	-0.82	0.6	1.0	-0.81	-0.14		0.43	-0.12	-0.94	1.0
Days Payables Outstanding	0.14	0.36	0.14	0.68	-0.51	-0.55	0.2	0.73	0.36	-0.14	-0.58	-0.36	-0.14	-0.77	0.63	-0.23	0.14	0.98	0.43	0.17	-0.73	0.43		-0.29	-0.23	0.46
Income Quality	0.11	-0.62	0.11	0.18	0.25	0.23	-0.19	-0.57	-0.62	-0.11	0.24	0.75	-0.1	0.65	-0.56	0.01	0.11	-0.31	-0.12	0.08	0.54	-0.12	-0.29		0.31	-0.06
Roe	0.93	-0.92	0.93	-0.59	0.94	0.91	-0.87	-0.12	-0.92	-0.93	0.9	0.82	-0.92	0.71	0.01	-0.87	0.93	-0.41	-0.94	0.91	0.13	-0.94	-0.23	0.31		-0.91
Ev To Operating Cash Flow	-0.78	0.75	-0.78	0.88	-0.98	-0.98	0.74	0.12	0.75	0.78	-0.98	-0.61	0.78	-0.71	-0.04	0.75	-0.78	0.63	1.0	-0.77	-0.13	1.0	0.46	-0.06	-0.91

Click cells to compare fundamentals

BioAffinity Technologies, Account Relationship Matchups

BioAffinity Technologies, fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Ptb Ratio	(4.06)	(3.88)	0.65	2.65	2.38	2.5
Book Value Per Share	(2.04)	(2.14)	2.45	0.56	0.5	0.52
Free Cash Flow Yield	(0.0361)	(0.0335)	(0.6)	(0.47)	(0.54)	(0.51)
Operating Cash Flow Per Share	(0.3)	(0.28)	(0.9)	(0.69)	(0.79)	(0.83)
Pb Ratio	(4.06)	(3.88)	0.65	2.65	2.38	2.5
Free Cash Flow Per Share	(0.3)	(0.28)	(0.95)	(0.69)	(0.8)	(0.84)
Roic	2.55	5.78	(0.36)	(1.24)	(1.43)	(1.36)
Net Income Per Share	(0.99)	(0.86)	(1.81)	(0.91)	(1.04)	(1.1)
Payables Turnover	0.12	0.0209	0.001353	2.88	2.59	2.72
Cash Per Share	0.0113	0.18	2.54	0.32	0.29	0.5
Pocfratio	(27.74)	(29.89)	(1.77)	(2.13)	(1.92)	(2.01)
Interest Coverage	(6.81)	(2.2)	(1.58)	(214.77)	(246.98)	(234.63)
Pfcf Ratio	(27.7)	(29.89)	(1.68)	(2.12)	(1.91)	(2.0)
Days Payables Outstanding	3.1K	17.5K	269.7K	126.8	114.12	108.42
Income Quality	0.3	0.32	0.5	0.76	0.68	0.42
Roe	0.48	0.4	(0.74)	(1.63)	(1.88)	(1.79)
Ev To Operating Cash Flow	(32.23)	(34.77)	0.97	(1.92)	(1.73)	(1.82)
Pe Ratio	(8.42)	(9.68)	(0.88)	(1.62)	(1.46)	(1.53)
Return On Tangible Assets	(49.92)	(4.35)	(0.67)	(1.33)	(1.19)	(1.25)
Ev To Free Cash Flow	(32.19)	(34.77)	0.92	(1.92)	(1.72)	(1.81)
Earnings Yield	(0.12)	(0.1)	(1.13)	(0.62)	(0.71)	(0.75)
Current Ratio	0.0107	0.11	10.5	1.77	1.59	2.0
Tangible Book Value Per Share	(2.04)	(2.14)	2.45	0.3	0.27	0.28
Shareholders Equity Per Share	(2.04)	(2.14)	2.45	0.56	0.5	0.52
Debt To Equity	(0.66)	(0.72)	0.0228	0.33	0.29	0.31
Graham Net Net	(2.05)	(2.15)	2.29	0.008376	0.007539	0.007915
Interest Debt Per Share	1.41	1.68	0.62	0.18	0.21	0.2
Debt To Assets	68.72	7.82	0.0207	0.19	0.22	0.21
Enterprise Value Over E B I T D A	(10.37)	(32.35)	0.71	(1.52)	(1.37)	(1.44)
Price Earnings Ratio	(8.42)	(9.68)	(0.88)	(1.62)	(1.46)	(1.53)
Price Book Value Ratio	(4.06)	(3.88)	0.65	2.65	2.38	2.5

Currently Active Assets on Macroaxis

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria
HMY	Harmony Gold Mining
FSM	Fortuna Silver Mines

When determining whether bioAffinity Technologies, is a strong investment it is important to analyze BioAffinity Technologies,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BioAffinity Technologies,'s future performance. For an informed investment choice regarding BioAffinity Stock, refer to the following important reports:

How To Invest In BioAffinity

Details

Is BioAffinity Stock a good investment?

Details

What is BioAffinity Technologies,'s Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more detail on how to invest in BioAffinity Stock please use our How to Invest in BioAffinity Technologies, guide.

You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAffinity Technologies,. If investors know BioAffinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAffinity Technologies, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.91)

Revenue Per Share

0.744

Quarterly Revenue Growth

120.474

Return On Assets

(0.70)

Return On Equity

(1.52)

The market value of bioAffinity Technologies, is measured differently than its book value, which is the value of BioAffinity that is recorded on the company's balance sheet. Investors also form their own opinion of BioAffinity Technologies,'s value that differs from its market value or its book value, called intrinsic value, which is BioAffinity Technologies,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAffinity Technologies,'s market value can be influenced by many factors that don't directly affect BioAffinity Technologies,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BioAffinity Technologies,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAffinity Technologies, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAffinity Technologies,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Short Term Coverage Ratios
Price Earnings Ratio	Operating Cycle
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Cash Conversion Cycle	Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding	Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio	Cash Flow Coverage Ratios
Price To Book Ratio	Fixed Asset Turnover
Capital Expenditure Coverage Ratio	Price Cash Flow Ratio
Enterprise Value Multiple	Debt Ratio
Cash Flow To Debt Ratio	Price Sales Ratio
Return On Assets	Asset Turnover
Net Profit Margin	Gross Profit Margin
Price Fair Value	Return On Equity

BioAffinity Historical Financial Ratios

About BioAffinity Financial Ratios Analysis

BioAffinity Technologies, Financial Ratios Chart

Price To Sales Ratio

Average Payables

Inventory Turnover

BioAffinity Technologies, fundamentals Correlations

BioAffinity Technologies, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioAffinity Technologies, fundamentals Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Days Sales Outstanding	+ 1.0	Price To Sales Ratio
Capex To Revenue	+ 1.0	Price To Sales Ratio
Interest Coverage	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Capex To Revenue	+ 1.0	Days Sales Outstanding
Interest Coverage	+ 1.0	Days Sales Outstanding

Capex To Revenue	- 1.0	Inventory Turnover
Interest Coverage	- 1.0	Ev To Sales
Capex To Revenue	- 1.0	Ev To Sales
Capex To Operating Cash Flow	- 1.0	Capex To Depreciation
Inventory Turnover	- 1.0	Days Sales Outstanding
Ev To Sales	- 1.0	Days Sales Outstanding